BioNTech SE (BioNTech SE) Price-to-Operating-Cash-Flow : 3.60 (As of Apr. 28, 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioNTech SE Price-to-Operating-Cash-Flow?

As of today (2024-04-28), BioNTech SE's share price is $87.21. BioNTech SE's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $24.23. Hence, BioNTech SE's Price-to-Operating-Cash-Flow Ratio for today is 3.60.

The historical rank and industry rank for BioNTech SE's Price-to-Operating-Cash-Flow or its related term are showing as below:

BNTX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.31 Med: 3.81 Max: 64.19
Current: 3.6

During the past 8 years, BioNTech SE's highest Price-to-Operating-Cash-Flow Ratio was 64.19. The lowest was 2.31. And the median was 3.81.

BNTX's Price-to-Operating-Cash-Flow is ranked better than
96.14% of 285 companies
in the Biotechnology industry
Industry Median: 24.65 vs BNTX: 3.60

BioNTech SE's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $3.86. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $24.23.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of BioNTech SE was -58.10% per year.

During the past 8 years, BioNTech SE's highest 3-Year average Operating Cash Flow per Share Growth Rate was 37.80% per year. The lowest was 37.80% per year. And the median was 37.80% per year.

BioNTech SE Price-to-Operating-Cash-Flow Historical Data

The historical data trend for BioNTech SE's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Price-to-Operating-Cash-Flow Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

66.60

2.61

4.37

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															2.61	3.55	2.78	4.53	4.37

Competitive Comparison of BioNTech SE's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, BioNTech SE's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNTech SE's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioNTech SE's Price-to-Operating-Cash-Flow falls into.

BioNTech SE Price-to-Operating-Cash-Flow Calculation

BioNTech SE's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	87.21	/	24.232
	=	3.60

BioNTech SE's Share Price of today is $87.21.
BioNTech SE's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.23.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

BioNTech SE Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (BioNTech SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (NAS:BNTX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.